Genor Biopharma changed its English name to Edding Genor Group Holdings Limited (HKG:6998), alongside a change in its Chinese name, according to a Tuesday Hong Kong bourse filing.
The move came following shareholder and regulatory approvals.
The pharmaceutical company's English stock short name will be changed to EDDING GENOR from GENOR effective 9:00 am on Feb. 6.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments